DMWD: A Potential Drug Target and Biomarker (G1762)

Target Name: DMWD

NCBI ID: G1762

DMWD

DMWD: A Potential Drug Target and Biomarker

DMWD is a protein that is expressed in various tissues and cells throughout the body. It is involved in a variety of cellular processes, including cell adhesion, migration, and invasion. DMWD has also been shown to play a role in cancer progression and treatment response. As a result, DMWD has potential as a drug target and biomarker.

DMWD and its Functions

DMWD is a member of the tight junction gene family, which encodes proteins that are involved in maintaining tissue tightness and cell-cell adhesion. It is composed of four transmembrane domains and a cytoplasmic tail. DMWD is expressed in a variety of tissues, including epithelial, neural, and connective tissue cells. It is involved in several cellular processes, including:

1. Cell Adhesion and Migration
DMWD is involved in cell adhesion and migration by playing a role in the formation of tight junctions and adherens junctions, which are complex structures that mediate cell-cell communication. tight junctions are a type of cell-cell adhesion that help to maintain tissue tightness, while adherens junctions are a type of cell-cell adhesion that help to maintain the integrity of tissues.

DMWD is also involved in the regulation of cell migration. It has been shown to play a role in the migration of various types of cancer cells, including breast, ovarian, and prostate cancer cells.

1. Oncogenic Effects
DMWD has also been shown to contribute to the oncogenic effects of several diseases, including cancer. For example, DMWD has been shown to promote the growth and survival of various types of cancer cells, including breast, ovarian, and prostate cancer cells. It has also been shown to contribute to the development of cancer-associated pain in humans.

1. Therapeutic Potential

DMWD has the potential as a drug target and biomarker due to its involvement in several cellular processes that are associated with disease. As a result, DMWD has been shown to be a promising target for a variety of therapeutic approaches, including anti-cancer agents, small molecules, and antibodies.

DMWD has been shown to be a potential drug target by its ability to interact with and inhibit the activity of several oncogenic signaling pathways. For example, DMWD has been shown to interact with and inhibit the activity of the TGF-β pathway, which is a well-established oncogenic pathway that is involved in the development of many types of cancer.

DMWD has also been shown to interact with and inhibit the activity of the NF-kappa-B pathway, which is another oncogenic pathway that is involved in the regulation of inflammation and pain.

DMWD has also been shown to interact with and inhibit the activity of the PI3K/AKT signaling pathway, which is involved in the regulation of cellular signaling and metabolism.

DMWD has also been shown to interact with and inhibit the activity of the PDGF signaling pathway, which is involved in the regulation of cell growth and differentiation.

Conclusion

DMWD is a protein that is involved in several cellular processes that are associated with disease. It has been shown to contribute to the oncogenic effects of several diseases, including cancer. As a result, DMWD has the potential as a drug target and biomarker. Further research is needed to fully understand the role of DMWD in disease and to develop effective therapies that target it.

Protein Name: DM1 Locus, WD Repeat Containing

The "DMWD Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DMWD comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets